Dermatology’s growing focus on skin longevity demands clear definitions, validated outcomes, and rigorous evidence beyond anti-aging claims.
|Articles|December 1, 2001
PDT for Actinic Cheilitis Merits Further Study
DALLAS - Photodynamic therapy (PDT) with topical 5-aminolevulinic acid (5-ALA) 20 percent may offer an alternative for treating actinic cheilitis, although further studies are needed to define usage parameters that will result in acceptably high response rates, Sarah B. Weitzul, M.D., said at the annual meeting of the American Society for Dermatologic Surgery.
Advertisement
Advertisement
Related to this article
Castor oil has become a popular social media remedy for thicker, longer hair, but evidence supporting its ability to stimulate hair growth remains limited.
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Advertisement
Advertisement
Trending on Dermatology Times
1
Lutikizumab Meets Primary End Point in Phase 3 HS Trial
2
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
3
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
4
Fall Clinical 2026: The Data and Expert Advice Shaping Dermatology Practice
5